This study examined the mechanism responsible for the selective induction of N-Pr-4-S-CAP-mediated anti-melanoma immunity by (a) cell depletion assay to identify effectors cells and (b) cross-presentation assay to clarify the involvement of CD8+ T cells in melanoma cell death. This evidence concerns the gene CD8A and melanoma.